Evolv Technology reported strong first quarter 2025 results, with revenue increasing 44% year-over-year to $32.0 million and Annual Recurring Revenue (ARR) reaching $106.0 million, up 34%. The company significantly reduced its net loss to $(1.7) million and achieved positive Adjusted EBITDA of $1.7 million.
Evolv Technology reported a 41% year-over-year increase in Q4 2024 revenue to $29.1 million, achieving positive adjusted EBITDA. The company also completed the restatement of previously issued financial statements, regaining compliance with SEC reporting and NASDAQ listing requirements.
Evolv Technology reported a 29% increase in revenue compared to the same quarter last year, reaching $25.5 million. The company also achieved net income of $3.5 million, a significant improvement from the net loss of $(66.8) million in the second quarter of 2023.
Evolv Technology announced its Q1 2024 financial results, with a revenue of $21.7 million, a 17% increase year-over-year. The Annual Recurring Revenue (ARR) reached $82.5 million, marking a 96% increase year-over-year. The company's net loss was $(11.6) million, or $(0.08) per share, and adjusted loss was $(13.1) million, or $(0.09) per share.
Evolv Technology reported a 4% increase in Q4 revenue year-over-year, reaching $21.8 million. The company's ARR grew by 120% to $75.0 million, and RPO increased by 66% to $240.5 million. Net loss decreased to $(16.9) million, or $(0.11) per share, compared to $(28.3) million, or $(0.20) per share in Q4 2022.
Evolv Technology announced strong Q3 2023 results, with revenue up 22% year-over-year to $20.2 million. The company's ARR increased by 129% year-over-year, reaching $65.8 million. Net income was $6.0 million, a significant improvement compared to the previous year's net loss.
Evolv Technology's Q2 2023 revenue reached $19.8 million, a 119% increase year-over-year, with ending ARR of $54.3 million, up 160% year-over-year. The company raised its business outlook for 2023.
Evolv Technology's first quarter 2023 revenue increased by 113% year-over-year to $18.6 million. The company raised its business outlook for 2023.
Evolv Technology reported strong Q4 results, highlighted by a 217% increase in revenue year-over-year and the addition of over 100 new customers. The company is well-positioned to achieve its goal of doubling Annual Recurring Revenue in 2023.
Evolv Technology reported a strong third quarter with a 96% increase in revenue year-over-year, driven by robust market adoption and expansion. The company also raised its business outlook for 2022.
Evolv Technology reported a strong second quarter with a 94% increase in revenue year-over-year, driven by the addition of over 50 new customers and continued expansion in key markets. The company surpassed 1,100 Evolv Express systems deployed and $100 million in cumulative TCV bookings. They reaffirmed their full year growth plans for 2022.
Evolv Technology reported a strong first quarter with a 118% increase in revenue compared to the previous year. The company's Total Contract Value and Annual Recurring Revenue also saw substantial growth. They reaffirmed their business outlook for 2022.
Evolv Technology reported strong Q4 2021 results with a 236% increase in revenue to $6.8 million compared to Q4 2020. The company also saw a 201% increase in Total Contract Value to $17.9 million and a 220% increase in Annual Recurring Revenue to $12.9 million. Net income for the quarter was $2.5 million, or $0.02 per share, compared to a net loss of $9.6 million, or $1.06 per share, for the fourth quarter of 2020.
Evolv Technology reported a significant increase in revenue for Q3 2021, with total revenue reaching $8.4 million, a 473% increase compared to Q3 2020. The company's TCV of orders booked also saw a substantial rise, increasing by 365% year-over-year to $16.9 million. GAAP net income for the quarter was $23.2 million, or $0.15 per diluted share.
Evolv Technology reported a 590% increase in revenue for the second quarter of 2021, reaching $4.5 million compared to $0.6 million in the same period last year. The company's TCV of orders booked also saw a substantial increase of 361%, amounting to $10.9 million. However, the GAAP net loss increased to $22.4 million, or $0.71 per share.